I agree that this site is using cookies. You can find further informations here.
X
Hussain, Azher
70  results:
Search for persons X
?
1

Single‐ and Multiple‐Dose Pharmacokinetics of Gefapixant (M..:

Nussbaum, Jesse C. ; Hussain, Azher ; Butera, Peter...
The Journal of Clinical Pharmacology.  64 (2024)  8 - p. 1023-1029 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Dose Optimization in Oncology Drug Development: An Internat..:

Samineni, Divya ; Venkatakrishnan, Karthik ; Othman, Ahmed A....
Clinical Pharmacology & Therapeutics.  , 2024
Link: https://doi.org/10.1002/..
 
?
3

Population pharmacokinetic analysis of the P2X3‐receptor an..:

Chawla, Akshita ; Largajolli, Anna ; Hussain, Azher...
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  8 - p. 1107-1118 , 2023
Link: https://doi.org/10.1002/..
 
?
4

Effects of Renal Impairment on the Pharmacokinetics of Gefa..:

Nussbaum, Jesse C. ; Hussain, Azher ; Min, K. Chris...
The Journal of Clinical Pharmacology.  62 (2022)  11 - p. 1435-1444 , 2022
Link: https://doi.org/10.1002/..
 
?
5

A Randomized, Placebo-Controlled Study to Investigate the S..:

Nussbaum, Jesse ; Hussain, Azher ; Ford, Anthony...
Lung.  , 2022
Link: https://doi.org/10.1007/..
 
?
6

Characterization of the absorption, metabolism, excretion, ..:

Nussbaum, Jesse C. ; Hussain, Azher ; Ma, Bennett...
Pharmacology Research & Perspectives.  10 (2022)  1 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
7

Clinical Formulation Bridging of Gefapixant, a P2X3‐Recepto..:

Gupta, Pranav ; Hussain, Azher ; Ford, Anthony P....
Clinical Pharmacology in Drug Development.  11 (2022)  9 - p. 1054-1067 , 2022
Link: https://doi.org/10.1002/..
 
?
8

Assessment of the Effect of Pyrimethamine, a Potent Inhibit..:

Nussbaum, Jesse C. ; Hussain, Azher ; Ma, Bennett...
Clinical Pharmacology in Drug Development.  11 (2021)  1 - p. 123-128 , 2021
Link: https://doi.org/10.1002/..
 
?
9

Assessment of Pharmacokinetic Interaction Between Gefapixan..:

McCrea, Jacqueline B. ; Hussain, Azher ; Ma, Bennett...
Clinical Pharmacology in Drug Development.  11 (2021)  3 - p. 406-412 , 2021
Link: https://doi.org/10.1002/..
 
?
10

Design and rationale of two phase 3 randomised controlled t..:

Muccino, David R. ; Morice, Alyn H. ; Birring, Surinder S....
ERJ Open Research.  6 (2020)  4 - p. 00284-2020 , 2020
Link: https://doi.org/10.1183/..
 
?
11

Population-Pharmacokinetic Modeling of Tildrakizumab (MK-32..:

Jauslin, Petra ; Kulkarni, Pooja ; Li, Hanbin...
Clinical Pharmacokinetics.  58 (2019)  8 - p. 1059-1068 , 2019
Link: https://doi.org/10.1007/..
 
?
12

Effect of tildrakizumab (MK‐3222), a high affinity, selecti..:

Khalilieh, Sauzanne ; Hussain, Azher ; Montgomery, Diana...
British Journal of Clinical Pharmacology.  84 (2018)  10 - p. 2292-2302 , 2018
Link: https://doi.org/10.1111/..
 
?
13

Controversy in the Allometric Application of Fixed- Versus ..:

Tang, Huadong ; Hussain, Azher ; Leal, Mauricio..
Journal of Pharmaceutical Sciences.  100 (2011)  2 - p. 402-410 , 2011
Link: https://doi.org/10.1002/..
 
?
14

Effect of reactive oxygen species on the metabolism of tryp..:

Hussain, Azher M. ; Mitra, Ashim K.
Molecular and Cellular Biochemistry.  258 (2004)  1/2 - p. 145-153 , 2004
Link: https://doi.org/10.1023/..
 
?
15

'Hand on hip' sign: A novel screening test and diagnostic t..:

Sadiq, Mohammed ; Hussain, Syed Azher ; Meganath, P
Journal of Orthopaedics, Trauma and Rehabilitation.  , 2020
Link: https://doi.org/10.1177/..
 
1-15